Harvard Bioscience (HBIO) Stock Price, Quote & News

Company Profile

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation a...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 508 893 8999

Fax: 508 429 5732

Website: www.harvardbioscience.com

Address:

84 October Hill Road, Suite 10, Holliston, United States

CEOBuysDisclosures Mar. 18 at 12:00 AM

$HBIO CEO purchased 5,000 shares at $5.01 for a total of $25,050. Duke John D now owns 105,000 shares. https://ceo-buys.com

0 · Reply

Axen7 Mar. 17 at 5:46 PM

$HBIO hope there is positive feedback today after the Healthcare forum

0 · Reply

TwongStocks Mar. 16 at 8:15 PM

Today's reverse split results. Nine reverse splits on NASDAQ today. 7 of 9 closed green. Part 1 of 2 $CLIR 1 for 10 Previous close $0.4328, $4.328 split-adjusted Intraday high $4.75 Today's close $4.355 🟢Up 0.62% $DXST 1 for 25 Previous close $0.2290, $5.725 split-adjusted Intraday high $7.99 Today's close $6.60 🟢Up 15.28% $HBIO 1 for 10 Previous close $0.4735, $4.735 split-adjusted Intraday high $5.25 Today's close $5.01 🟢Up 5.81% $MASK.X 1 for 25 Previous close $0.1354, $3.385 split-adjusted Intraday high $3.92 Today's close $3.22 🔴Down 4.87% $NIVF 1 for 4 Previous close $0.5700, $2.28 split-adjusted Intraday high $2.43 Today's close $2.34 🟢Up 2.63% No splits scheduled on NASDAQ tomorrow.

0 · Reply

topstockalerts Mar. 16 at 4:13 PM

$HBIO Not a bad session at all for momentum traders 🙌. Price moved cleanly higher. Buyers stayed in control.

1 · Reply

chinchinbull Mar. 16 at 3:41 PM

$ZSPC vs $WNW vs $HBIO vs $ULY

0 · Reply

erevnon Mar. 16 at 2:57 PM

Benchmark maintains Harvard Bioscience $HBIO at Speculative Buy and raises the price target from $0.6 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

StockNews_Live Mar. 16 at 2:53 PM

$HBIO stock splitted to ~5 with Target of 6. Wow just wow.

0 · Reply

DARKP00L Mar. 16 at 2:41 PM

$HBIO

0 · Reply

mirage282828 Mar. 16 at 2:05 PM

$HBIO so what's going to happen to my May 15th calls

1 · Reply

anachartanalyst Mar. 16 at 2:01 PM

$HBIO https://anachart.com/wp-content/uploads/ana_temp/1773669680_soc-img.jpg

0 · Reply

Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript

Mar 12, 2026, 7:30 AM EDT - 5 days ago

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Mar 6, 2026, 4:01 PM EST - 11 days ago

Harvard Bioscience Announces Reverse Stock Split

Mar 3, 2026, 7:30 AM EST - 14 days ago

Harvard Bioscience to Participate in KeyBanc's Virtual Healthcare Forum

Feb 26, 2026, 7:30 AM EST - 19 days ago

Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET

Feb 10, 2026, 7:30 AM EST - 5 weeks ago

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

Jan 29, 2026, 4:30 PM EST - 6 weeks ago

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

Dec 17, 2025, 7:30 AM EST - 3 months ago

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

Nov 7, 2025, 2:16 AM EST - 4 months ago

Harvard Bioscience, Inc. (HBIO) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 7:00 AM EST - 4 months ago

Harvard Bioscience Announces Third Quarter 2025 Financial Results

Oct 30, 2025, 8:00 AM EDT - 4 months ago

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET

Sep 16, 2025, 7:00 AM EDT - 6 months ago

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

Sep 9, 2025, 7:00 AM EDT - 6 months ago

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

Aug 11, 2025, 9:54 AM EDT - 7 months ago

Harvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 7:00 AM EDT - 7 months ago

Harvard Bioscience Announces Second Quarter 2025 Financial Results

Aug 4, 2025, 4:30 PM EDT - 8 months ago

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Jul 17, 2025, 7:00 AM EDT - 8 months ago

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Jun 2, 2025, 4:57 PM EDT - 10 months ago

Harvard Bioscience Appoints John Duke to Board of Directors

May 12, 2025, 12:41 PM EDT - 11 months ago

Harvard Bioscience, Inc. (HBIO) Q1 2025 Earnings Call Transcript

May 12, 2025, 7:00 AM EDT - 11 months ago

Harvard Bioscience Announces First Quarter 2025 Financial Results

May 5, 2025, 4:45 PM EDT - 11 months ago

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

Apr 10, 2025, 4:45 PM EDT - 1 year ago

Harvard Bioscience Announces CFO Transition

Mar 12, 2025, 4:00 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

Mar 12, 2025, 11:19 AM EDT - 1 year ago

Harvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 7:21 AM EDT - 1 year ago

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

Feb 24, 2025, 4:45 PM EST - 1 year ago

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

Feb 24, 2025, 11:00 AM EST - 1 year ago

Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

Jan 13, 2025, 5:52 PM EST - 1 year ago

Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

Nov 9, 2024, 9:37 AM EST - 1 year ago

Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 5:00 PM EDT - 1 year ago

Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

Sep 18, 2024, 7:30 AM EDT - 1 year ago

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting

Sep 5, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference

Aug 11, 2024, 7:09 AM EDT - 1 year ago

Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Harvard Bioscience Announces Second Quarter 2024 Financial Results

Aug 2, 2024, 8:00 AM EDT - 1 year ago

Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET

Jun 6, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

May 23, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024

May 16, 2024, 4:05 PM EDT - 1 year ago

Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference

May 7, 2024, 12:52 PM EDT - 2 years ago

Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Call Transcript

May 7, 2024, 7:00 AM EDT - 2 years ago

Harvard Bioscience Announces First Quarter 2024 Financial Results

Apr 29, 2024, 8:45 AM EDT - 2 years ago

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

Apr 9, 2024, 9:00 AM EDT - 2 years ago

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth

Mar 11, 2024, 8:00 AM EDT - 2 years ago

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

Mar 7, 2024, 9:56 AM EST - 2 years ago

Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 7:00 AM EST - 2 years ago

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results

Feb 27, 2024, 5:10 PM EST - 2 years ago

Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET

Nov 20, 2023, 4:40 PM EST - 2 years ago

Harvard Bioscience to Present at Benchmark Company's Discovery One-On-One Investor Conference on December 7, 2023

Nov 9, 2023, 4:30 PM EST - 2 years ago

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

Nov 7, 2023, 2:08 PM EST - 2 years ago

Harvard Bioscience, Inc. (HBIO) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 7:00 AM EST - 2 years ago

Harvard Bioscience Announces Third Quarter 2023 Financial Results

CEOBuysDisclosures Mar. 18 at 12:00 AM

$HBIO CEO purchased 5,000 shares at $5.01 for a total of $25,050. Duke John D now owns 105,000 shares. https://ceo-buys.com

0 · Reply

Axen7 Mar. 17 at 5:46 PM

$HBIO hope there is positive feedback today after the Healthcare forum

0 · Reply

TwongStocks Mar. 16 at 8:15 PM

0 · Reply

topstockalerts Mar. 16 at 4:13 PM

$HBIO Not a bad session at all for momentum traders 🙌. Price moved cleanly higher. Buyers stayed in control.

1 · Reply

chinchinbull Mar. 16 at 3:41 PM

$ZSPC vs $WNW vs $HBIO vs $ULY

0 · Reply

erevnon Mar. 16 at 2:57 PM

Benchmark maintains Harvard Bioscience $HBIO at Speculative Buy and raises the price target from $0.6 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

StockNews_Live Mar. 16 at 2:53 PM

$HBIO stock splitted to ~5 with Target of 6. Wow just wow.

0 · Reply

DARKP00L Mar. 16 at 2:41 PM

$HBIO

0 · Reply

mirage282828 Mar. 16 at 2:05 PM

$HBIO so what's going to happen to my May 15th calls

1 · Reply

anachartanalyst Mar. 16 at 2:01 PM

$HBIO https://anachart.com/wp-content/uploads/ana_temp/1773669680_soc-img.jpg

0 · Reply

Axen7 Mar. 16 at 2:01 PM

$HBIO alright a little green here!

0 · Reply

DARKP00L Mar. 16 at 1:42 PM

$HBIO 09:26 on Mar. 16 2026 Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6 #tradeideas

0 · Reply

TwongStocks Mar. 16 at 12:30 PM

$CLIR $DXST $HBIO $MASK.X $NIVF Nine NASDAQ stocks with reverse splits today. Trading scheduled to resume at 9:00am ET with the RS in effect. RS details in the quoted post.

0 · Reply

sentinelles Mar. 14 at 8:35 PM

$IVF The company has announced a 1-for-4 reverse stock split effective March 16, 2026. $MASK.X On March 11, 2026, the company announced a 25-for-1 share consolidation. This means every 25 old shares will be combined into 1 new share. $HBIO The stock is expected to begin trading on a split-adjusted basis on Monday, March 16, 2026.

2 · Reply

FreeBeerTomorrow Mar. 14 at 9:50 AM

$HBIO * Harvard Bioscience (HBIO) is scheduled to begin trading on a split-adjusted basis this coming Monday, March 16, 2026. Ratio: 1-for-10 . Estimated Public Float: ~3.57 million shares.

0 · Reply

TwongStocks Mar. 13 at 8:05 PM

Nine(!!!) NASDAQ reverse splits scheduled on Monday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. Have to split this post into two parts. PART 1 $CLIR 1 for 10. Will reduce outstanding shares from approx 54.1m to approx 5.41m. $DXST 1 for 25. Will reduce outstanding shares from approx 40.38m to approx 1.62m. $HBIO 1 for 10. Will reduce outstanding shares from approx 44.72m to approx 4.47m. $MASK.X 1 for 25. Will reduce outstanding shares from approx 28.24m to approx 1.13m. $NIVF 1 for 4. Will reduce outstanding shares from approx 2.27m to approx 568k.

1 · Reply

anachartanalyst Mar. 13 at 2:01 PM

$HBIO https://anachart.com/wp-content/uploads/ana_temp/1773410495_soc-img.jpg

0 · Reply

DARKP00L Mar. 13 at 1:31 PM

$HBIO 08:48 on Mar. 13 2026 Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6 #tradeideas

0 · Reply

TwongStocks Mar. 12 at 7:39 PM

$HBIO Equity Corporate Actions Alert #2026 - 157 Information Regarding the Reverse Stock Split and CUSIP Number Change for Harvard Bioscience, Inc. (HBIO) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-157 Harvard Bioscience, Inc. (HBIO) will effect a one-for-ten (1-10) reverse split of its Common Stock. The reverse stock split will become effective on Monday, March 16, 2026. In conjunction with the reverse split, the CUSIP number will change to 416906204.

0 · Reply

WestVirginian Mar. 12 at 4:30 PM

$HBIO bought a bit on that dip

0 · Reply

Nj126677 Mar. 12 at 3:55 PM

$HBIO

0 · Reply

Market Cap	2.12M
Revenue (ttm)	94.14M
Net Income (ttm)	-12.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	4.30
Profit Margin	-13.18%
Debt to Equity Ratio	2.41

Volume	82,200
Avg Vol	45,923
Day's Range	N/A - N/A
Shares Out	4.47M
Stochastic %K	46%
Beta	1.51
Analysts	Sell
Price Target	$2.00